Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avita Medical (RCEL)
NASDAQ:RCEL
Holding RCEL?
Track your performance easily
RCEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.51 - $18.93
Previous Close$9.36
Volume100.10K
Average Volume (3M)185.81K
Market Cap
$243.26M
Enterprise Value$233.48M
Total Cash (Recent Filing)$54.06M
Total Debt (Recent Filing)$44.27M
Price to Earnings (P/E)―
Beta2.16
Next Earnings
Nov 07, 2024EPS Estimate
-$0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding25,989,699
10 Day Avg. Volume92,544
30 Day Avg. Volume185,812
Standard Deviation0.20
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)7.60
Price to Sales (P/S)4.80
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.31
Enterprise Value/Gross Profit5.51
Enterprise Value/Ebitda-5.15
Forecast
1Y Price Target
$21.25Price Target Upside127.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Avita Medical News
PremiumPress Releases
AVITA Medical to Host Investor Webinar Briefing
PremiumCompany Announcements
Avita Medical Strikes Exclusive Deal for Collagen-Based Product
Bulls Say, Bears Say
Bulls Say
Product LaunchAvita has launched advanced dressings and will soon commercialize a proprietary dermal matrix.
Regulatory ApprovalThe U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the RECELL GO™ System.
Revenue GrowthThe company has demonstrated that its flagship RECELL platform is generating nice traction, as evidenced by the 29% revenue growth performance.
Bears Say
Financial PerformanceThe company is lowering its guidance to $68.0M-$70.0M, down from $78.5M-$84.5M previously.
Management CredibilityManagement’s credibility has been strained and investors are worried the Company will not hit what some believe is still aggressive guidance for the year.
Operational ChallengesAccount growth is still tracking below initial expectations, indicating slower-than-anticipated progress.
---
Ownership Overview
2.80% Insiders
9.84% Mutual Funds
11.12% Other Institutional Investors
76.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCEL FAQ
What was Avita Medical’s price range in the past 12 months?
Avita Medical lowest stock price was $7.51 and its highest was $18.93 in the past 12 months.
What is Avita Medical’s market cap?
Currently, no data Available
When is Avita Medical’s upcoming earnings report date?
Avita Medical’s upcoming earnings report date is Nov 07, 2024 which is in 61 days.
How were Avita Medical’s earnings last quarter?
Avita Medical released its earnings results on Aug 08, 2024. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.482 by -$0.118.
Is Avita Medical overvalued?
According to Wall Street analysts Avita Medical’s price is currently Undervalued.
Does Avita Medical pay dividends?
Avita Medical does not currently pay dividends.
What is Avita Medical’s EPS estimate?
Avita Medical’s EPS estimate is -$0.44.
How many shares outstanding does Avita Medical have?
Avita Medical has 25,989,698 shares outstanding.
What happened to Avita Medical’s price movement after its last earnings report?
Avita Medical reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.482. Following the earnings report the stock price went up 20.681%.
Which hedge fund is a major shareholder of Avita Medical?
Among the largest hedge funds holding Avita Medical’s share is Hussman Strategic Advisors Inc. It holds Avita Medical’s shares valued at 333K.
---
Avita Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.25 (127.03% Upside)
$21.25 (127.03% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 14.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.03%
12-Months-Change
Fundamentals
Return on Equity
-107.66%
Trailing 12-Months
Asset Growth
1.73%
Trailing 12-Months
Company Description
Avita Medical
Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
---
RCEL Company Deck
---
RCEL Earnings Call
Q2 2024
0:00 / 0:00
---
RCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
---
RCEL Stock 12 Month Forecast
Average Price Target
$21.25
▲(127.03% Upside)
Technical Analysis
Best Analysts Covering RCEL
1 Year
1 Year Success Rate
5/18 ratings generated profit
1 Year Average Return
-20.98%
assigned a buy rating 29 days ago
Copying Brooks O'Neil's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of -20.98% per trade.
---